Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice

Martine Bot, Paul P. Van Veldhoven, Saskia C. A. de Jager, Jason Johnson, Niels Nijstad, Peter J. Van Santbrink, Marijke M. Westra, Gerd Van Der Hoeven, Marion J. Gijbels, Carsten Mueller-Tidow, Georg Varga, Uwe J. F. Tietge, Johan Kuiper, Theo J. C. Van Berkel, Jerzy-Roch Nofer, Ilze Bot, Erik A. L. Biessen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalPLOS ONE
Volume8
Issue number6
DOIs
Publication statusPublished - 20 May 2013

Cite this

Bot, M., Van Veldhoven, P. P., de Jager, S. C. A., Johnson, J., Nijstad, N., Van Santbrink, P. J., Westra, M. M., Van Der Hoeven, G., Gijbels, M. J., Mueller-Tidow, C., Varga, G., Tietge, U. J. F., Kuiper, J., Van Berkel, T. J. C., Nofer, J-R., Bot, I., & Biessen, E. A. L. (2013). Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice. PLOS ONE, 8(6). https://doi.org/10.1371/journal.pone.0063360